Blood sugar monitoring If you are using tirzepatide for diabetes management, increase blood sugar monitoring frequency when phentermine is added
1 capsule, 1-3 times per day, or as directed by your practitioner
1 Dual agonism of GIP and GLP-1 receptors is a promising new approach currently in clinical development for the treatment of diabetes, obesity, and associated complications [1] The incretin effect defines the main physiological role of GIP and GLP-1 GIP and GLP-1 increase insulin secretion following nutrient-induced secretion from the gut (incretin effect): There is a stronger insulin secretion response to oral compared to 'isoglycemic' intravenous glucose administration due to secretion and action of incretin hormones
[PubMed ID: 34955820]
(1) Mealtime + basal insulin: Adjust the insulin dosage before three meals according to the blood glucose level before lunch, dinner, and bedtime respectively
Elizabeth McDonald, of the University of Pennsylvania Perelman School of Medicine, said: "While our study was observational and does not definitively confirm an association between GLP-1 medications and reduced breast cancer incidence, it does add to the growing body of evidence suggesting that it's worth investigating these weight-loss drugs as potential cancer prevention tools." GLP-1 medications are a class of drugs that mimic a natural hormone in the body called glucagon-like peptide-1, which helps regulate blood sugar and appetite
